• ورود به سامانه
      مشاهده مورد 
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Pharmaceutical Research
      • Volume 18, Issue 2
      • مشاهده مورد
      •   صفحهٔ اصلی
      • نشریات انگلیسی
      • Iranian Journal of Pharmaceutical Research
      • Volume 18, Issue 2
      • مشاهده مورد
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      Characterization of Novel Fragment Antibodies Against TNF-alpha Isolated Using Phage Display Technique

      (ندگان)پدیدآور
      Alizadeh, Ali AkbarHamzeh-Mivehroud, MaryamHaddad, ElnazHaddad, NazaninSharifi, MehdiMohammadi, SaminPourtaghi, SamiraDastmalchi, Siavoush
      Thumbnail
      دریافت مدرک مشاهده
      FullText
      اندازه فایل: 
      1.544 مگابایت
      نوع فايل (MIME): 
      PDF
      نوع مدرک
      Text
      Research article
      زبان مدرک
      English
      نمایش کامل رکورد
      چکیده
      Tumor necrosis factor alpha (TNF-α) is an inflammatory cytokine which plays crucial roles in pathogenesis of inflammatory diseases. The current study aimed to investigate the binding abilities of I44 and I49 domain antibodies to TNF-α. The dAbs were expressed in bacterial expression system and purified by affinity chromatography using Ni-sepharose column. The expression and purity of the proteins were evaluated using western blotting and SDS-PAGE techniques, respectively. ELISA experiment showed that I44 and I49 dAbs bind to TNF-α with the binding constants (Kd) of 5.18 ± 1.41 and 2.42 ± 0.55 µM, respectively. The inhibitory effect of dAbs on TNF-α biological effect was determined in MTT assay in which I44 and I49 prevented TNF-α cell cytotoxicity with IC50 values of 6.61 and 3.64 µM, respectively. The identified anti-TNF-α dAbs could bind to and inhibit TNF-α activity. The dAbs activities can be attributed to their ability to establish hydrogen bonds as well as hydrophobic contacts with TNF-α. The results of the current study can pave the way for further structural studies in order to introduce new more potent anti-TNF-α antibodies.
      کلید واژگان
      TNF-α
      Domain antibodies
      Recombinant protein production
      Molecular docking
      Phage display
      Pharmacutical biotechnology

      شماره نشریه
      2
      تاریخ نشر
      2019-05-01
      1398-02-11
      ناشر
      School of Pharmacy, Shahid Beheshti University of Medical Sciences
      سازمان پدید آورنده
      Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
      Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. | School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
      School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
      School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
      School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. | Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
      School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
      School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.
      Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.| School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. |Faculty of Pharmacy, Near East University, POBOX: 99138, Nicosia, North Cyprus, Mersin 10, Turkey.

      شاپا
      1735-0328
      1726-6890
      URI
      https://dx.doi.org/10.22037/ijpr.2019.1100646
      http://ijpr.sbmu.ac.ir/article_1100646.html
      https://iranjournals.nlai.ir/handle/123456789/313002

      مرور

      همه جای سامانهپایگاه‌ها و مجموعه‌ها بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌هااین مجموعه بر اساس تاریخ انتشارپدیدآورانعناوینموضوع‌‌ها

      حساب من

      ورود به سامانهثبت نام

      تازه ترین ها

      تازه ترین مدارک
      © کليه حقوق اين سامانه برای سازمان اسناد و کتابخانه ملی ایران محفوظ است
      تماس با ما | ارسال بازخورد
      قدرت یافته توسطسیناوب